Case Presentation: CREATED BY-Pharmacology SGD 1A
Case Presentation: CREATED BY-Pharmacology SGD 1A
Case Presentation: CREATED BY-Pharmacology SGD 1A
PRESENTATION
CREATED BY- Pharmacology SGD 1A
MEMBERS OF SGD 1A
• ARKAPRAVO MONDAL – 2301298
• SAGAR PRATIK MAHESHBHAI- 2201236
• AFRIN SHAIKH- 2301740
• MUDE NAVEEN NAIK- 2301638
• VEMBARASAN SUBHRAMANIYAN- 2301340
• SURAJ RAJU-2301358
• RAJKUMAR CHELLAMUTHU PANDIAN – 2301821
• YUKTHI PRAKASH VEMAGAL PRAKASH- 2301830
• POORNESH MURUGAN 2301346
• SAMUDRALA TEJASWINI SHARON – 2301794
• NALLABOTHULA JAGADHEESWAR – 2301516
• PATEL LUCKY- 2301602
• KAVYA THANGAVEL – 2301716
• SHAH RISHABKUMAR 2200856
• AVINASH KANODIA – 2201163
• GUPTA SADHANA VIRENDRA – 2201038
• DURGESH BHIWRAN – 2301578
• ASHWIN PATIDAR- 2200826
• POORVI DUBE - 2200968
A 58-year-old female, came in with recent onset chest discomfort when jogging or swimming
vigorously. The pain is dull but poorly localized; it disappears after 5–10 minutes of rest. She also
presents with a blood pressure of 150/100 during her check up at the clinic. She admits on having
elevated blood during her visits in the clinic with BP range of 140-150/80 for the last month. She is a
known hypertensive for 5 years and is on Metoprolol 50 mg once daily. She is a nondiabetic and is
apparently healthy. She is living a sedentary lifestyle with occasional exercise and her meals are
mostly fast food. She is a non-smoker and non-alcoholic beverage drinker with a strong family history
of hypertension and coronary artery disease on both sides of the family.
A)
C) PULMONARY D) CHEST WALL
GASTROESOPHAGEAL B) PEPTIC ULCER
EMBOLISM INJURY
REFLUX
01 02 03
A) Monitor blood B) Monitor lipid levels to C) Assess angina
pressure regularly to assess the response to symptoms and the
assess the response to lipid-lowering therapy frequency of episodes to
antihypertensive therapy and adjust treatment evaluate the effectiveness
and ensure target levels of anti-anginal therapy.
are achieved.
DESIRED END POINTS OF TREATMENT!
01 02 03
A) Achieve and maintain B) Attain and maintain C) Provide effective relief
target blood pressure optimal lipid levels, from angina symptoms
levels of less than 130/80 including LDL cholesterol and reduce the frequency
mmHg to reduce the risk levels below 100 mg/dL, and severity of angina
of cardiovascular events. to reduce the risk of episodes.
coronary artery disease
progression.
• Schedule a follow-up visit in 4-6 weeks to
Follow assess treatment response, side effects, and
make further adjustments if necessary.
up!!
• Monitor for potential side effects of
medications, especially any signs of
intolerance to the increased dose of
Metoprolol or Atorvastatin.
IMPORTANT . Emphasize adherence to the prescribed
CONSIDERATIONS!! medications and lifestyle modifications